<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="survRM2adapt">
<title>Vignette for the ltrmst2adapt function in the survRM2adapt package • survRM2adapt</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.rawgit.com/afeld/bootstrap-toc/v1.0.1/dist/bootstrap-toc.min.js"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Vignette for the ltrmst2adapt function in the survRM2adapt package">
<meta property="og:description" content="survRM2adapt">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-inverse navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">survRM2adapt</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="Released version">1.1.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="active nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/vignette-survRM2adapt.html">Vignette for the ltrmst2adapt function in the survRM2adapt package</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/uno1lab/survRM2adapt">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Vignette for the ltrmst2adapt function in the survRM2adapt package</h1>
                        <h4 data-toc-skip class="author">Miki
Horiguchi<a class="footnote-ref" tabindex="0" data-bs-toggle="popover" data-bs-content='&lt;p&gt;Dana-Farber Cancer Institute, &lt;a href="mailto:horiguchimiki@gmail.com" class="email"&gt;horiguchimiki@gmail.com&lt;/a&gt;&lt;/p&gt;'><sup>1</sup></a>, Hajime Uno<a class="footnote-ref" tabindex="0" data-bs-toggle="popover" data-bs-content='&lt;p&gt;Dana-Farber Cancer Institute, &lt;a href="mailto:huno@ds.dfci.harvard.edu" class="email"&gt;huno@ds.dfci.harvard.edu&lt;/a&gt;&lt;/p&gt;'><sup>2</sup></a>
</h4>
            
            <h4 data-toc-skip class="date">March 23, 2023</h4>
      
      
      <div class="d-none name"><code>vignette-survRM2adapt.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="introduction">1 Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>Cancer immunotherapy is an important treatment option for cancer
patients, and clinical trials that evaluate immunotherapy will
increasingly be conducted toward optimizing cancer management. Unlike
cytotoxic agents, immunotherapies do not attack the cancer cell directly
but utilize the immune system to do so. This unique approach leads to
the possibility of delayed treatment effects, but when successful can
deliver long-lasting benefits for treated patients.</p>
<p>A 2020 study<span class="math inline">\(^{1}\)</span> showed that, in
almost all cancer phase III randomized controlled trials, the log-rank
test and Cox’s hazard ratio (HR) are used for testing the equality of
the survival functions and estimating the magnitude of the treatment
effect, respectively. However, the log-rank test may not be powerful
enough to capture the delayed treatment effect we often see in
immunotherapy studies. In addition, the basis of the traditional Cox’s
HR method is the proportional hazards (PH) assumption which assumes that
the hazard functions from two groups are constant over the study time.
It has been shown that the PH assumption does not hold in most
immunotherapy studies. Therefore, the conventional analysis methods
using the log-rank test and HR estimation may be suboptimal, and
development of alternative approaches are critical for the successful
development of immunotherapy.</p>
<p>The long-term restricted mean survival time (LT-RMST) and the
adaptive (or flexible) version of the LT-RMST have been proposed for
possible application to immunotherapy studies.<span class="math inline">\(^{2-4}\)</span> In this vignette, we briefly
review these methods and illustrate how to implement them using the
<em>ltrmst2adapt</em> function in the <em>survRM2adapt</em> package. The
package was made and tested on R version 4.2.3.</p>
</div>
<div class="section level2">
<h2 id="installation">2 Installation<a class="anchor" aria-label="anchor" href="#installation"></a>
</h2>
<p>Open the R or RStudio applications. Then, copy and paste either of
the following scripts to the command line.</p>
<p>To install the package from the CRAN:</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span class="fu"><a href="https://rdrr.io/r/utils/install.packages.html" class="external-link">install.packages</a></span><span class="op">(</span><span class="st">"survRM2adapt"</span><span class="op">)</span></code></pre></div>
<p>To install the development version:</p>
<div class="sourceCode" id="cb2"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span class="fu"><a href="https://rdrr.io/r/utils/install.packages.html" class="external-link">install.packages</a></span><span class="op">(</span><span class="st">"devtools"</span><span class="op">)</span> <span class="co">#-- if the devtools package has not been installed</span>
<span class="fu">devtools</span><span class="fu">::</span><span class="fu"><a href="https://devtools.r-lib.org/reference/remote-reexports.html" class="external-link">install_github</a></span><span class="op">(</span><span class="st">"uno1lab/survRM2adapt"</span><span class="op">)</span></code></pre></div>
</div>
<div class="section level2">
<h2 id="sample-reconstructed-data">2 Sample Reconstructed Data<a class="anchor" aria-label="anchor" href="#sample-reconstructed-data"></a>
</h2>
<p>Throughout this vignette, we use sample data which we reconstructed
from the CheckMate214 study reported by Motzer et al.<span class="math inline">\(^{5}\)</span> The data consists of 847 patients
with previously untreated clear-cell advanced renal-cell carcinoma; 425
for the nivolumab plus ipilimumab group (treatment) and 422 for the
sunitinib group (control).</p>
<p>The sample reconstructed data from the CheckMate214 study is
available on <em>survRM2adapt</em> package as <em>cm214_pfs</em>. To
load the data, copy and paste the following scripts to the command
line.</p>
<div class="sourceCode" id="cb3"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va">survRM2adapt</span><span class="op">)</span>

<span class="fu"><a href="https://rdrr.io/r/base/nrow.html" class="external-link">nrow</a></span><span class="op">(</span><span class="va">cm214_pfs</span><span class="op">)</span>
<span class="co">#&gt; [1] 847</span>

<span class="va">cm214_pfs</span><span class="op">[</span><span class="fl">1</span><span class="op">:</span><span class="fl">10</span>,<span class="op">]</span>
<span class="co">#&gt;     time status arm</span>
<span class="co">#&gt; 1  0.451      1   1</span>
<span class="co">#&gt; 2  0.451      1   1</span>
<span class="co">#&gt; 3  0.451      1   1</span>
<span class="co">#&gt; 4  0.451      1   1</span>
<span class="co">#&gt; 5  0.451      1   1</span>
<span class="co">#&gt; 6  0.710      1   1</span>
<span class="co">#&gt; 7  0.710      1   1</span>
<span class="co">#&gt; 8  0.710      1   1</span>
<span class="co">#&gt; 9  0.919      1   1</span>
<span class="co">#&gt; 10 0.919      1   1</span></code></pre></div>
<p>Here, <strong>time</strong> is months from the registration to
progression-free survival (PFS), <strong>status</strong> is the
indicator of the event (1: event, 0: censor), and <strong>arm</strong>
is the treatment assignment indicator (1: Treatment group, 0: Control
group).</p>
<p>Below are the Kaplan-Meier estimates for the PFS for each treatment
group.</p>
<p><img src="vignette-survRM2adapt_files/figure-html/unnamed-chunk-4-1.png" width="576"></p>
</div>
<div class="section level2">
<h2 id="long-term-restricted-mean-survival-time-lt-rmst">3 Long-Term Restricted Mean Survival Time (LT-RMST)<a class="anchor" aria-label="anchor" href="#long-term-restricted-mean-survival-time-lt-rmst"></a>
</h2>
<p>Let <span class="math inline">\(S\)</span> be the survival function
for the event time. The LT-RMST is defined as <span class="math display">\[R(\eta, \tau) = \int_\eta^\tau S(s)ds,\]</span>
where <span class="math inline">\([\eta, \tau]\)</span> is a fixed range
within the study time <span class="math inline">\((0&lt;\eta&lt;\tau)\)</span>. <span class="math inline">\(R(\eta, \tau)\)</span> can be estimated
nonparametrically using the Kaplan-Meier estimator <span class="math inline">\(\hat{S}\)</span>. It can be interpretated as
average survival time during the time range <span class="math inline">\([\eta, \tau]\)</span> (i.e., the time treatment
effect appears until the specific time <span class="math inline">\(\tau\)</span>) and provide a clinically
interpretable treatment effect associated with a long-lasting survival
benefit for treated patients. Standardized by the width of the time
window <span class="math inline">\([\eta, \tau]\)</span>, <span class="math display">\[\frac{R(\eta, \tau)}{\tau-\eta}\]</span> can be
interpreted as an average survival probability on <span class="math inline">\([\eta, \tau]\)</span> or average proportion of the
time range spent alive.</p>
<p>For between-group comparison, we consider <span class="math display">\[D(\eta, \tau) = R_{1}(\eta, \tau)-R_{0}(\eta,
\tau)\]</span> as a summary measure of the magnitude of the treatment
effect. The asymptotic properties of <span class="math inline">\(\hat{D}(\eta, \tau)\)</span> can be seen in Zhao
et al.<span class="math inline">\(^{2}\)</span></p>
</div>
<div class="section level2">
<h2 id="adaptive-long-term-restricted-mean-survival-time-adaptive-lt-rmst">4 Adaptive Long-Term Restricted Mean Survival Time (adaptive
LT-RMST)<a class="anchor" aria-label="anchor" href="#adaptive-long-term-restricted-mean-survival-time-adaptive-lt-rmst"></a>
</h2>
<p>A challenge of the LT-RMST estimation would be specifying <span class="math inline">\(\eta\)</span> for the approximate time point where
the treatment effect will begin to appear. We have proposed the adaptive
LT-RMST-based test/estimation methods to get around this
limitation.<span class="math inline">\(^{4}\)</span> This method is a
modified version of the LT-RMST test/estimation methods with improved
flexibility in choosing <span class="math inline">\(\eta\)</span>.
Specifically, instead of choosing one specific value of <span class="math inline">\(\eta\)</span>, we specify a time range or a set of
time values where <span class="math inline">\(\eta\)</span> value can be
included. For example, if we expect the treatment effect to appear
sometime between 6 to 12 months, a time range <span class="math inline">\(B = \{b|b \in [6,12]\}\)</span> (months) can be
prespecified. The procedure selects one time value as <span class="math inline">\(\eta\)</span> among <span class="math inline">\(B\)</span> that can detect the treatment effect
with the most statistical significance, which is not always the time
point of separation of the two survival curves.</p>
<p>For testing the null hypothesis using the adaptive LT-RMST (i.e.,
<span class="math inline">\(H_{0}: D(\eta, \tau)=0\)</span> for all
<span class="math inline">\(\eta \in B\)</span>), the following test
statistic is used:</p>
<p><span class="math display">\[\sup_{b \in B} \left| D(b,\tau) /
\sqrt{V(W_n(b,\tau))/n}\right|.\]</span> The procedure derives the
reference distribution of the test statistic using a zero-mean Gaussian
process with the covariance function of the process <span class="math inline">\(W_n(\eta,\tau) \in B\)</span> to obtain a p-value
and a corresponding <span class="math inline">\((1-\alpha)\)</span>
simultaneous confidence bands for <span class="math inline">\(D(b,\tau)\)</span>. The detailed procedure is
given in the full paper.<span class="math inline">\(^{4}\)</span></p>
<p>During the procedure, the largest value of <span class="math inline">\(\eta\)</span>, say, <span class="math inline">\(\eta^{*}\)</span>, that satisfies <span class="math display">\[\left|\hat{D}(\eta^{*},
\tau)/\sqrt{\hat{V}(W_n(\eta^{*},\tau))/n}\right|=\sup_{b \in
B}\left|\hat{D}(b, \tau)/\sqrt{\hat{V}(W_n(b,\tau))/n}\right|\]</span>
is chosen. A <span class="math inline">\((1-\alpha)\)</span> confidence
interval (CI) for <span class="math inline">\(D(\eta^{*},\tau)\)</span>
is then given by <span class="math display">\[\hat{D}(\eta^{*}, \tau)
\pm c_{\alpha}\sqrt{\hat{V}(W_n(\eta^{*},\tau))/n},\]</span> where <span class="math inline">\(c_{\alpha}\)</span> is derived using the reference
distribution.</p>
</div>
<div class="section level2">
<h2 id="implementation-of-long-term-rmst-testestimation-methods">5 Implementation of Long-Term RMST Test/Estimation Methods<a class="anchor" aria-label="anchor" href="#implementation-of-long-term-rmst-testestimation-methods"></a>
</h2>
<p>The procedure below shows how to use the function,
<strong>ltrmst2adapt</strong>, to implement the LT-RMST method with a
pre-specified <span class="math inline">\(\eta\)</span>.</p>
<div class="sourceCode" id="cb4"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span class="fu"><a href="../reference/ltrmst2adapt.html">ltrmst2adapt</a></span><span class="op">(</span>indata<span class="op">=</span><span class="va">cm214_pfs</span>, tau1<span class="op">=</span><span class="fl">3</span>, tau2<span class="op">=</span><span class="fl">10</span>, seed<span class="op">=</span><span class="fl">123</span><span class="op">)</span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST over the time window [3,10] </span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST(arm1) RMST(arm0) </span>
<span class="co">#&gt;      4.415      4.191 </span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST(arm1-arm0)      lower 0.95      upper 0.95         p_value </span>
<span class="co">#&gt;           0.224          -0.209           0.657           0.312</span></code></pre></div>
<p>The first argument (<strong>indata</strong>) is the data frame you
want to analyze. The 1st column is the time-to-event variable, the 2nd
column is the event indicator (1=event, 0=censor), and the 3rd column is
the treatment indicator (1=treatment, 0=control). No missing values are
allowed in this data matrix. The second argument (<strong>tau1</strong>)
is an integer value indicating the lower end of the time window (<span class="math inline">\(\eta\)</span>). The third argument
(<strong>tau2</strong>) is an integer value indicating the upper end of
the time window (<span class="math inline">\(\tau\)</span>). The fourth
argument (<strong>seed</strong>) is an integer value for random number
generation in the resampling procedures.</p>
<p>When a fixed value is specified as <strong>tau1</strong>, the
<strong>ltrmst2adapt</strong> function returns RMST over the time window
[<span class="math inline">\(\tau_{1}\)</span>, <span class="math inline">\(\tau_{2}\)</span>] on each group and the results
of the between-group contrast measure (difference in the LT-RMST between
the two groups). The estimated LT-RMSTs were 4.415 months and 4.191
months for the treatment group and the control group, respectively. The
difference between the LT-RMSTs was 0.224 months (95% CI: -0.209 to
0.657, p-value=0.312).</p>
</div>
<div class="section level2">
<h2 id="implementation-of-adaptive-long-term-rmst-testestimation-methods">6 Implementation of adaptive Long-Term RMST Test/Estimation
Methods<a class="anchor" aria-label="anchor" href="#implementation-of-adaptive-long-term-rmst-testestimation-methods"></a>
</h2>
<p>Instead of specifying a fixed value of <span class="math inline">\(\eta\)</span>, the procedure below allows us to
specify a set of values for <span class="math inline">\(\eta\)</span>,
say, 0, 1, 2, and 3.</p>
<div class="sourceCode" id="cb5"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span class="fu"><a href="../reference/ltrmst2adapt.html">ltrmst2adapt</a></span><span class="op">(</span>indata<span class="op">=</span><span class="va">cm214_pfs</span>, tau1<span class="op">=</span><span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0</span>,<span class="fl">1</span>,<span class="fl">2</span>,<span class="fl">3</span><span class="op">)</span>, tau2<span class="op">=</span><span class="fl">10</span>, seed<span class="op">=</span><span class="fl">123</span><span class="op">)</span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST over the time window [3,10] </span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST(arm1) RMST(arm0) </span>
<span class="co">#&gt;      4.415      4.191 </span>
<span class="co">#&gt; </span>
<span class="co">#&gt; RMST(arm1-arm0)      lower 0.95      upper 0.95         p_value </span>
<span class="co">#&gt;           0.224          -0.218           0.666           0.332</span></code></pre></div>
<p>Here, the second argument (<strong>tau1</strong>) is a vector
indicating the set of values for the lower end of the time window (<span class="math inline">\(\eta\)</span>). The first, third, and fourth
arguments are the same as specified in Section 5.</p>
<p>The <strong>ltrmst2adapt</strong> function returns RMST over the time
window [<span class="math inline">\(\tau_{1}^{*}\)</span>, <span class="math inline">\(\tau_{2}\)</span>] on each group and the results
of the between-group contrast measure (difference in the LT-RMSTs),
where <span class="math inline">\(\tau_{1}^{*}\)</span> is the
adaptively selected value among the specified values as
<strong>tau1</strong>. With this example, 3 was selected as <span class="math inline">\(\tau_{1}^{*}\)</span> among the candidates (0, 1,
2, and 3). The estimated LT-RMSTs for both groups and the difference
between them were the same as the ones in the LT-RMSTs with fixed <span class="math inline">\(\eta\)</span> in Section 5. The 95% CI for the
difference was slightly wider (-0.218 to 0.666) than the LT-RMST with
fixed <span class="math inline">\(\eta\)</span>, and the p-value was
also slightly larger (0.332). These results suggest that the efficiency
loss by adopting the flexibility in the adaptive LT-RMST method is not
remarkable, compared to the LT-RMST with fixed <span class="math inline">\(\eta\)</span>.</p>
</div>
<div class="section level2">
<h2 id="conclusions">7 Conclusions<a class="anchor" aria-label="anchor" href="#conclusions"></a>
</h2>
<p>The function, <em>ltrmst2adapt()</em>, in the <em>survRM2adapt</em>
package can easily implement the LT-RMST-based statistical comparison
with a pre-specified <span class="math inline">\(\eta\)</span> and also
with a data-dependent choice of <span class="math inline">\(\eta\)</span>, which we have called the adaptive
LT-RMST approach in this vignette.</p>
<p>The adaptive LT-RMST approach does not require users to pre-specify a
single number for <span class="math inline">\(\eta\)</span> but rather a
set of candidates for <span class="math inline">\(\eta\)</span>, making
the adaptive LT-RMST approach more flexible than the LT-RMST approach
with a fixed <span class="math inline">\(\eta\)</span>.</p>
<p>Both approaches provide estimates of the magnitude of the treatment
effect that do not depend on the study-specific censoring distribution.
They also offer greater power than the traditional Cox regression
approach to detect the treatment effect when the delayed survival
benefit is expected, and thus will be particularly useful for clinical
trials evaluating the efficacy and safety of cancer immunotherapies.</p>
</div>
<div class="section level2">
<h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<ol style="list-style-type: decimal">
<li><p>Uno H, Horiguchi M, Hassett MJ (2020). Statistical
test/estimation methods used in contemporary phase III cancer randomized
controlled trials with time-to-event outcomes. <em>Oncologist</em>,
25(2):91-93. <a href="https://doi.org/10.1634/theoncologist.2019-0464" class="external-link uri">https://doi.org/10.1634/theoncologist.2019-0464</a></p></li>
<li><p>Zhao L, Tian L, Uno H, et al (2012). Utilizing the integrated
difference of two survival functions to quantify the treatment contrast
for designing, monitoring, and analyzing a comparative clinical study.
<em>Clinical Trials</em>, 9(5):570-7. <a href="https://doi.org/10.1177/1740774512455464" class="external-link uri">https://doi.org/10.1177/1740774512455464</a></p></li>
<li><p>Horiguchi M, Tian L, Uno H et al (2018). Quantification of
long-term survival benefit in a comparative oncology clinical study.
<em>JAMA Oncology</em>, 4(6):881-882. <a href="https://doi.org/10.1001/jamaoncol.2018.0518" class="external-link uri">https://doi.org/10.1001/jamaoncol.2018.0518</a></p></li>
<li><p>Horiguchi M, Tian L, Uno H. On assessing survival benefit of
immunotherapy using long-term restricted mean survival time.
<em>Statistics in Medicine</em>, 42(8):1139-1155. <a href="https://doi.org/10.1002/sim.9662" class="external-link uri">https://doi.org/10.1002/sim.9662</a></p></li>
<li><p>Motzer RJ, Tannir NM, McDermott DF, et al. (2018). Nivolumab plus
ipilimumab versus sunitinib in advanced renal-cell carcinoma. <em>New
England Journal of Medicine</em>, 378(14):1277-1290. <a href="https://doi.org/10.1056/NEJMoa1712126" class="external-link uri">https://doi.org/10.1056/NEJMoa1712126</a></p></li>
</ol>
</div>
<div class="section level2">
<h2 id="notes">Notes<a class="anchor" aria-label="anchor" href="#notes"></a>
</h2>
<p>See also the vignette for the survRM2 package for details on the
implementation of the RMST-based test/estimation approaches. <a href="https://CRAN.R-project.org/package=survRM2" class="external-link uri">https://CRAN.R-project.org/package=survRM2</a></p>
</div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p></p>
<p>Developed by Miki Horiguchi, <a href="https://web.stanford.edu/~lutian/home.HTML" class="external-link">Lu Tian</a>, <a href="https://ds.dfci.harvard.edu/~huno/" class="external-link">Hajime Uno</a>.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6.</p>
</div>

    </footer>
</div>

  

  

  </body>
</html>
